Poster Download
Call for Abstracts of Foreign Invited Speakers
Abstract submission for designated sessions
Please refer to the following guideline, and access to the registration screen from the button "Abstract Submission" located at the bottom of this page.
- Author information and abstracts must be submitted in English.
- Abstract title must be up to 120 single-byte characters.
- Abstract text must be up to 2,000 single-byte characters.
- The maximum of 20 authors (first author & co-authors) can be registered.
- The maximum of 20 affiliations (including the affiliation of the first author) can be registered.
Publication in "Annals of Oncology"
The submitted English abstracts for JSMO 2019 Meeting will be published in ESMO/JSMO Scientific Journal, supplement to "Annals of Oncology" (Oxford University Press).
If you wish to have your abstract published in "Annals of Oncology," please select "Yes".
* Note: We accept encore abstracts for presentations as long as the abstract has a new view on the topic or being updated with subset analysis. However, if your abstract is an encore abstract it cannot be included in "Annals of Oncology." Please select "No" for the question.
Disclosure of Conflict of Interest (COI)
The presenter (the first author) and the principal investigator must disclose the name of any company or for-profit organization related to medicine they have a relationship with, defined as follows: in the following items (3) to (9), (11), (12), exceeding separately stipulated criteria, and (1), (2), (10), (13) if met. The subject period is from January 1, 2016 - December 31, 2018.
Detailed Enforcement regulations of COI (in revision)
For oral presentation, please use the slide below as a template to disclose conflict of interest.
For poster presentation, please prepare and print out the slide, and put it at lower right of the poster panel.
| (1) | If your study for this presentation is supported by research funds |
|---|---|
| (2) | If you are or have been an employee of a company and/or a profit-making organization related to medicine |
| (3) | If you have earned ＞￥1,000,000/year as an officer or advisor of a company and/or a profit-making organization related to medicine |
| (4) | If you hold＞5％ of the stock of a company and/or a profit-making organization related to medicine, or receive dividends ＞￥1,000,000/year |
| (5) | If you have earned ＞￥1,000,000/year as a patent fee from a company and/or a profit-making organization related to medicine |
| (6) | If you have earned ＞￥500,000/year as a lecture fee from a company and/or a profit-making organization related to medicine |
| (7) | If you have earned ＞￥500,000/year as a manuscript fee from a company and/or a profit-making organization related to medicine |
| (8) | If you have research expenses ＞￥1,000,000/year from a company and/or a profit-making organization related to medicine |
| (9) | If you have received ＞￥1,000,000/year as a certain contribution from a company and/or a profit-making organization related to medicine |
| (10) | If you are or have been involved in a certain endowed chair funded by a company and/or a profit-making organization related to medicine |
| (11) | If you have ＞￥1,000,000/year as a fee for expert comment, judgment or testimony in legal proceedings, or others from a company and/or a profit-making organization related to medicine |
| (12) | If you have received remuneration (travel, gifts, or other in-kind payments not directly related to research）equivalent to ＞￥50,000/year from a company and/or a profit-making organization related to medicine |
| (13) | If you are a representative of an organization for clinical study which receives research expenses（donation, contract, others）from a company and/or a profit-making organization related to medicine |
To view the PDF files, you may need, "Adobe Reader"(Download Adobe Reader)
Questions regarding COI disclosure
The Secretariat of the Japanese Society of Medical Oncology
E-mail: 
Abstract Submission
Confirmation / Modification / Deletion of submitted abstract & Additional submission
Confirmation / Modification / Deletion / Additional submission
Inquiries for Abstract Submission
Congress Secretariat
c/o Congress Corporation
5-1 Koji-machi, Chiyoda-ku, Tokyo, Japan
Phone: +81-3-5216-5318 Fax: +81-3-5216-5552
E-mail: jsmo2019-endai@congre.co.jp
